OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
Marina Salmón, Ruth Álvarez, Coral Fustero‐Torre, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 33
Marina Salmón, Ruth Álvarez, Coral Fustero‐Torre, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
Targeted KRASG12Vdegradation elicits efficient and durable lung adenocarcinoma regressionin vivo
Alberto J. M. Martín, Inmaculada García-Peréz, Sonia San José, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alberto J. M. Martín, Inmaculada García-Peréz, Sonia San José, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Intratumor heterogeneity in KRAS signaling shapes treatment resistance
Oleksi Petrenko, Varvara Kirillov, Stephen D’Amico, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111662-111662
Open Access
Oleksi Petrenko, Varvara Kirillov, Stephen D’Amico, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111662-111662
Open Access
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Adeno-to-squamous transition drives resistance to KRAS inhibition inLKB1mutant lung cancer
Xinyuan Tong, Ayushi Patel, Eejung Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Xinyuan Tong, Ayushi Patel, Eejung Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton, Sandra Stickler, Barbara Rath
Exploration of Targeted Anti-tumor Therapy (2023), pp. 1027-1038
Open Access | Times Cited: 1
Gerhard Hamilton, Sandra Stickler, Barbara Rath
Exploration of Targeted Anti-tumor Therapy (2023), pp. 1027-1038
Open Access | Times Cited: 1
SIGNATURE-DRIVEN REPURPOSING OF MIDOSTAURIN FOR COMBINATION WITH MEK1/2 AND KRASG12C INHIBITORS IN LUNG CANCER
Silvestre Vicent, Irati Macaya, Marta Leytón Román, et al.
Research Square (Research Square) (2023)
Open Access
Silvestre Vicent, Irati Macaya, Marta Leytón Román, et al.
Research Square (Research Square) (2023)
Open Access
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma
Zhuxuan Li, Xueqian Zhuang, Chun‐Hao Pan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Zhuxuan Li, Xueqian Zhuang, Chun‐Hao Pan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
miRNA Profiling of 3'UTR Variations in Sporadic Lung Carcinoma Tumours
Özkan Bağcı
Research Square (Research Square) (2023)
Open Access
Özkan Bağcı
Research Square (Research Square) (2023)
Open Access
